|Table of Contents|

An analysis of malignant tumors incidence and mortality in Fuzhou,2018

Journal Of Modern Oncology[ISSN:1672-4992/CN:61-1415/R]

Issue:
2023 18
Page:
3481-3485
Research Field:
Publishing date:

Info

Title:
An analysis of malignant tumors incidence and mortality in Fuzhou,2018
Author(s):
LI Hong; XU Youqiong; ZHENG Wanhui; LU Lu
Fuzhou Center for Disease Prevention and Control,Fujian Fuzhou 350004,China.
Keywords:
malignant tumor; epidemiology; Fuzhou
PACS:
R73-31
DOI:
10.3969/j.issn.1672-4992.2023.18.027
Abstract:
Objective:To analyze the incidence and mortality of malignant tumors in Fuzhou in 2018,and provide theoretical basis for the control and prevention of malignant tumors.Methods:The data of malignant tumors in Fuzhou in 2018 were collected and evaluated.The crude incidence and mortality,the age-standardized rate by Chinese standard population (ASR China) and by world standard population (ASR world),the constituent ratio,and the cumulative incidence rate (0~74 years old) were calculated.The common malignant tumors were analyzed.Results:In 2018,the crude incidence rate in Fuzhou was 288.36/100 000.ASR China and ASR world were 196.53/100 000 and 190.15/100 000.The cumulative rate (0~74 years old) was 21.91%.The mortality rate of malignant tumors in Fuzhou was 160.72/100 000,with ASR China of 98.02/100 000 and ASR world of 96.55/100 000,and the cumulative rate (0~74 years old) was 11.10%.Lung cancer,breast cancer,gastric cancer,colorectal cancer and thyroid cancer were the most common malignant tumors in Fuzhou.The top five malignant tumors were lung cancer,gastric cancer,liver cancer,colorectal cancer and thyroid cancer in male,and lung cancer,breast cancer,thyroid cancer,colorectal cancer and gastric cancer in female.Conclusion:In 2018,the incidence and mortality of malignant tumors in Fuzhou were comparable to that in Fujian Province.The incidence of gastric cancer was higher,and the incidences of liver cancer and esophageal cancer were lower than that in Fujian Province.Lung cancer,female breast cancer,and gastric cancer were the most important malignant tumors,and should be the focus of cancer control and prevention in Fuzhou.

References:

[1] SUNG H,FERLAY J,SIEGEL RL,et al.Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries［J］.CA:A Cancer Journal for Clinicians,2021,71(3):209-249.
[2] 曹毛毛,陈万青.中国恶性肿瘤流行情况及防控现状［J］.中国肿瘤临床,2019,46(3):145-149. CAO MM,CHEN WQ.Epidemiology of cancer in China and the current status of prevention and control［J］.Chinese Journal of Clinical Oncology,2019,46(3):145-149.
[3] 国家癌症中心.中国肿瘤登记工作指导手册(2016)［M］.北京:人民卫生出版社,2016:59-75. National Cancer Center.Chinese guideline for cancer registration(2016)［M］.Beijing:People's Medical Publishing House,2016:59-75.
[4] 陈传本.2021福建省肿瘤登记年报［M］.福州:福建科学技术出版社,2022:15-23. CHEN CB.Fujian cancer registry annual report,2021［M］.Fuzhou:Fujian Science Technology Publishing House,2022:15-23.
[5] 宫舒萍,房巧玲,王旭峰,等.2018年济南市恶性肿瘤登记质量评价与发病分析［J］.预防医学论坛,2021,27(1):4-9. GONG SP,FANG QL,WANG XF,et al.Analysis on quality evaluation and incidence of malignant tumor registry,Jinan city,2018［J］.Preventive Medicine Tribune,2021,27(1):4-9.
[6] 邹艳花,廖先珍,许可葵,等.2018年湖南省肿瘤登记地区恶性肿瘤发病与死亡分析［J］.中国肿瘤,2022,31(4):241-248. ZOU YH,LIAO XZ,XU KK,et al.Cancer incidence and mortality in Hunan cancer registration areas in 2018［J］.China Cancer,2022,31(4):241-248.
[7] 陈万青,孙可欣,郑荣寿,等.2014年中国分地区恶性肿瘤发病和死亡分析［J］.中国肿瘤,2018,27(1):1-14. CHEN WQ,SUN KX,ZHENG RS,et al.Report of cancer incidence and mortality in different areas of China,2014［J］.China Cancer,2018,27(1):1-14.
[8] 丁贤彬,吕晓燕,焦艳,等.2010-2018年重庆市恶性肿瘤发病死亡趋势分析［J］.现代肿瘤医学,2020,28(24):4351-4358. DING XB,LYU XY,JIAO Y,et al.Trend of incidence and mortality of cancer in Chongqing,2010-2018［J］.Modern Oncology,2020,28(24):4351-4358.
[9] 吕艺,张馨予,赵雪,等.2011-2018年沈阳市城区恶性肿瘤发病及生存趋势分析［J］.肿瘤防治研究,2022,49(8):806-811. LYU Y,ZHANG XY,ZHAO X,et al.Incidence and survival trend of malignant tumors in Shenyang urban area from 2011 to 2018［J］.Cancer Research on Prevention and Treatment,2022,49(8):806-811.
[10] 潘睿.中国慢性病前瞻性研究队列恶性肿瘤发病与死亡分析［D］.南京：南京医科大学,2017. PAN R.Cancer incidence and mortality：a cohort study in China abstract［D］.Nanjing:Nanjing Medical University,2017.
[11] MEYERS TJ,CHANG SC,CHANG PY,et al.Case-control Study of cumulative cigarette tar exposure and lung and upper aerodigestive tract cancers:cigarette tar exposure and lung and UADT cancers［J］.International Journal of Cancer,2017,140(9):2040-2050.
[12] YIN Z,CUI Z,LI H,et al.Polymorphisms in miR-135a-2,miR-219-2 and miR-211 as well as their interaction with cooking oil fume exposure on the risk of lung cancer in Chinese nonsmoking females:a case-control study［J］.BMC Cancer,2016,16(1):751.
[13] YOUN HJ,HAN W.A review of the epidemiology of breast cancer in asia:focus on risk factors［J］.Asian Pacific Journal of Cancer Prevention,2020,21(4):867-880.
[14] 张柏林,韩彬彬,王翔,等.女性乳腺癌发病危险因素的病例-对照研究［J］．癌症进展,2017,15(4):395-398. ZHANG BL,HAN BB,WANG X,et al.A case-control study on risk factors of breast cancer in females［J］.Oncology Progress,2017,15(4):395-398.
[15] POOROLAJAL J,MORADI L,MOHAMMADI Y,et al.Risk factors for stomach cancer:a systematic review and Meta-analysis［J］.Epidemiology and Health,2020,42:e2020004.

Memo

Memo:
-
Last Update: 1900-01-01